Proton Pump Inhibitors Market Growth Accelerated by Rising Incidence of Gastroesophageal Reflux Disease
Proton pump inhibitors are popular drugs used to reduce stomach acid and provide relief from acid reflux and ulcers. Proton pump inhibitors work by inhibiting the pumping mechanism that produces stomach acid. They are frequently prescribed for conditions like GERD, acid reflux, duodenal ulcers, and gastric ulcers. Rising prevalence of gastrointestinal disorders such as GERD has been a major driver of growth for the proton pump inhibitors market. The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3.29 Bn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The market has witnessed robust growth due to the increasing prevalence of GERD. A recent study published in the American Journal of Gastroenterology reports that nearly 20% of the U.S. adult population experiences symptoms of GERD at least once a week. The prevalence of GERD is attribu...